ACHL

ACHL


Acute Myeloid Leukemia: What’s New on the Horizon

Rapid progress in the treatment of Acute Myeloid Leukemia (AML) has resulted in a substantial volume of new clinical literature and updated guidelines. 8 new therapies have been approved since 2017 alone. Clinicians must remain well-versed with novel treatment options for newly diagnosed patients and those with relapsed/refractory AML and need education on advances in targeted therapies for AML....
ACHL

Assessing Department-specific Antibiotic Susceptibility to Guide Selection and Improve Outcomes - Management of cUTIs

A faculty panel will discuss a case relating to the assessment and treatment of cUTIs. Topics will include emerging technologies for diagnosis, common pathogens, and the selection of therapy for resistant gram-negative infections. The purpose of this activity is to provide members of antimicrobial stewardship programs and clinicians who care for patients with serious infections with the l...
ACHL

Assessing Department-specific Antibiotic Susceptibility to Guide Selection and Improve Outcomes - Selection of Therapy for HAP/VAP

This activity will feature a faculty panel discussing the treatment of a patient with HAP/VAP. Discussions will center around resistant gram-negative pathogens, the selection of therapy, and the role of newer antimicrobial therapies. The purpose of this activity is to provide members of antimicrobial stewardship programs and clinicians who care for patients with serious infections with ...
ACHL

At-risk Populations and Prevention of HPV-related Cancers: From Children to Adults

The purpose of this activity is to educate diverse clinicians on the burden of HPV infections and recent data demonstrating the safety and population benefits of HPV vaccination in the prevention of HPV-related cancers. Armed with this information, clinicians can effectively counsel patients on the importance of vaccination.
ACHL

Clinical Case Challenges: Strategies to Optimize Primary Immunodeficiency Management

Primary care providers, internists, and other general practitioners may be the first to see a patient with PI and require a level of awareness. Yet, a survey issued by the American Academy of Allergy Asthma and Immunology and the Immune Deficiency Foundation found that only 4% of primary care practitioners were aware that guidelines existed for the diagnosis and management of primary immunodefic...
ACHL

Complex Psoriasis Patients and Challenging Areas to Treat

Areas of plaque psoriasis that are particularly challenging to treat are more common than previously thought, and these areas may not respond as well to traditional treatment approaches. Moreover, they are associated with lower patient quality of life. Clinicians can provide valuable patient-centered care for these psoriasis manifestations by facilitating discussions about treatment goals and fo...
ACHL

Exploring the Future of IBD Care: The Role of JAK Inhibitors

Advance your understanding on new and innovative approaches to care, focusing on the role of JAK Inhibitors in the treatment of IBD. Leading US gastroenterology faculty recently gave a series of lectures across the country on the latest research and treatment regimen recommendations in IBD to enhance optimal health outcomes. Thomas Ullman, MD, Chief of the Division of Gastroenterology at Mon...
ACHL

From Diagnosis to Treatment: The Evolution of SSc-ILD

Explore this 45-minute multi-media eNewsletter that will advance your understanding of systemic sclerosis interstitial lung disease (SSc-ILD) with Dr. Ganesh Raghu, Director of the University of Washington Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program. While there have been significant advances in our understanding of SSc-ILD, there are important unmet needs that still must be...
ACHL

How Social Determinants Impact Disparities in Diabetes Care: New Paradigms and Patient Perspectives

In this interactive infographic format, Monica Peek, MD, MPH, MSc, uses her clinical and community experience to provide perspectives on disparities in diabetes care. Using videos, audio, and animated content, this highly visual, self-directed platform creates a practical framework to translate awareness of patient, clinician, and macro-level contributors to disparities into clinical care. Strat...
ACHL

JAK-STAT-GO: Personalized, Targeted Therapy Options for Your IBD Patients

How can clinicians know they have current information for improving patients’ IBD outcomes? Expert faculty from the Icahn School of Medicine at Mount Sinai, University of Chicago Medicine and Biological Sciences, and Montefiore Medical Center/Albert Einstein College of Medicine recently led a symposium at a major gastroenterology meeting exploring the latest in treat-to-target paradigms, the r...
ACHL

Needs Across the Patient Continuum: The Intersection of Energy and Protein

Symposium highlights held in conjunction with the ASPEN 2020 Nutrition Science and Practice Conference. The nutritional needs of critically ill patients during hospitalization and after discharge are complex, and the importance of assessing energy expenditure and tailoring nutritional therapies to the individual is increasingly apparent. Although a great deal of study is still needed, accumul...
ACHL

New Developments in PAH: Practice Strategies with Competing Novel PAH Guidelines

This interactive infographic format provides up-to-date information on disease classification, risk stratification, and diagnostic and treatment algorithms for PAH. Using a highly visual self-directed platform, Dan Schuller, MD, creates a practical framework to translate CHEST guideline updates for PAH diagnosis and treatment into clinical practice. Learners navigate at their own pace through an...
ACHL

Optimizing Antibiotic Therapy to Treat Gram-negative Pathogens and Improve Outcomes in HAP/VAP

George Karam, MD reviews a HAP/VAP patient case presented along with a faculty panel at MAD-ID 2019. Discussion topics include challenges with P. aeruginosa, ensuring effectiveness of antibiotics while reducing resistance, as well as new and emerging approaches to Gram-negative organisms. The purpose of this activity is to provide clinicians who care for patients with serious infections with...
ACHL

The Evolving Role of Nutrition Therapy in the Hospitalized Patient: Focus on Lipids and Protein

Despite recognition of underfeeding in hospital settings and its consequences, a substantial number of hospitalized patients can be characterized as malnourished. In this roundtable discussion, Canadian and US-based faculty discuss diagnostic criteria for malnutrition, available and emerging lipid emulsion products and their influence on inflammation and ensuring adequate protein delivery for op...
ACHL

The Right Drugs at the Right Time: The Cost-Savings Case for Tying PAH Formulary Protocols to Best Available Clinical Evidence

Our expert faculty, comprised of a managed care pharmacist and pulmonologist specializing in PAH, review recent guideline recommendations and strategies for selecting appropriate therapy, including initial combination regimens, as well as financial considerations based on managed care pharmacy protocols. Therapeutic selection and management in PAH are intertwined with differential diagnostics...
ACHL

Understanding the Microbiome and Gut Microbiota

In this video commentary, Dr. Amy Barto will examine the role of the gut microbiome in initial and recurrent C. difficile infection. She will also discuss risk factors for recurrent infection and will introduce available and emerging approaches to microbial restoration
ACHL

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.